Incidence and mortality rates of selected infection-related cancers in Puerto Rico and in the United States.
BACKGROUND
In 2002, 17.8% of the global cancer burden was attributable to infections. This study assessed the age-standardized incidence and mortality rates of stomach, liver, and cervical cancer in Puerto Rico (PR) for the period 1992-2003 and compared them to those of Hispanics (USH), non-Hispanic Whites (NHW), and non-Hispanic Blacks (NHB) in the United States (US).


METHODS
Age-standardized rates [ASR(World)] were calculated based on cancer incidence and mortality data from the PR Cancer Central Registry and SEER, using the direct method and the world population as the standard. Annual percent changes (APC) were calculated using the Poisson regression model from 1992-2003.


RESULTS
The incidence and mortality rates from stomach, liver and cervical cancer were lower in NHW than PR; with the exception of mortality from cervical cancer which was similar in both populations. Meanwhile, the incidence rates of stomach, liver and cervical cancers were similar between NHB and PR; except for NHB women who had a lower incidence rate of liver cancer than women in PR. NHB had a lower mortality from liver cancer than persons in PR, and similar mortality from stomach cancer.


CONCLUSIONS
The burden of liver, stomach, and cervical cancer in PR compares to that of USH and NHB and continues to be a public health priority. Public health efforts are necessary to further decrease the burden of cancers associated to infections in these groups, the largest minority population groups in the US. Future studies need to identify factors that may prevent infections with cancer-related agents in these populations. Strategies to increase the use of preventive strategies, such as vaccination and screening, among minority populations should also be developed.
Ortiz
Ana P
AP
Cancer Control and Population Sciences Program, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico. ana.ortiz7@upr.edu.
Soto-Salgado
Marievelisse
M
Calo
William A
WA
Tortolero-Luna
Guillermo
G
Pérez
Cynthia M
CM
Romero
Carlos J
CJ
Pérez
Javier
J
Figueroa-Vallés
Nayda
N
Suárez
Erick
E
J Infect Dis. 1996 Oct;174(4):679-89
8843203
Pathology. 2005 Dec;37(6):409-19
16373224
MMWR Morb Mortal Wkly Rep. 2006 May 12;55(18):509-11
16691181
Int J Epidemiol. 1993 Oct;22(5):790-7
8282456
BMC Infect Dis. 2010 Mar 23;10:76
20331884
BMC Cancer. 2009 Apr 28;9:129
19400958
J Acquir Immune Defic Syndr. 2009 May 1;51 Suppl 1:S13-20
19384096
Helicobacter. 2009 Jun;14(3):159-71
19702845
CA Cancer J Clin. 2003 Jul-Aug;53(4):208-26
12924775
JAMA. 2007 Feb 28;297(8):813-9
17327523
J Acquir Immune Defic Syndr. 1999 Aug 1;21 Suppl 1:S27-30
10430215
Stat Med. 2000 Feb 15;19(3):335-51
10649300
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2162-9
19661072
J Infect Dis. 1999 Jun;179(6):1523-30
10228075
Cancer Res. 1975 Nov;35(11 Pt. 2):3265-71
1238165
MMWR CDC Surveill Summ. 2000 Jul 7;49(6):1-39
10910404
Am J Public Health. 1999 Jan;89(1):14-8
9987458
Soc Sci Med. 2005 Sep;61(6):1243-55
15970234
Bol Asoc Med P R. 1991 Jun;83(6):258-60
1930479
Fam Plann Perspect. 1999 Sep-Oct;31(5):228-36
10723647
N Engl J Med. 1999 Mar 11;340(10):745-50
10072408
Rev Med Chil. 2006 Jun;134(6):777-88
17130955
MMWR Morb Mortal Wkly Rep. 2009 Jun 5;58(21):589-91
19498337
Am J Hum Genet. 2007 Sep;81(3):626-33
17701908
Carcinogenesis. 2010 Jan;31(1):100-10
19934210
Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25
16949997
J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):164-9
11242184
MMWR Surveill Summ. 2006 Jul 14;55(7):1-124
16837896
Crit Rev Oncol Hematol. 2009 Jun;70(3):183-94
18805702
J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27
16204691
Ann Intern Med. 2006 May 16;144(10):705-14
16702586
Cancer. 2000 Jun 1;88(11):2642-52
10861444
Obstet Gynecol. 1997 Jan;89(1):76-80
8990442
J Infect Dis. 2000 Apr;181(4):1359-63
10762567
P R Health Sci J. 2009 Jun;28(2):105-13
19530551
Cancer Causes Control. 2006 Oct;17(8):1067-75
16933057
Int J Cancer. 2006 Jun 15;118(12):3030-44
16404738
Pediatr Infect Dis J. 2001 Nov;20(11 Suppl):S30-3
11704721
World J Gastroenterol. 2006 Jan 21;12(3):354-62
16489633
J Urban Health. 2008 Nov;85(6):826-56
18709555
Vaccine. 2000 Feb 18;18 Suppl 1:S17-9
10683537
Rev Panam Salud Publica. 2009 May;25(5):394-400
19695128
N Engl J Med. 1991 Oct 17;325(16):1132-6
1891021
Stat Methods Med Res. 2006 Dec;15(6):547-69
17260923
P R Health Sci J. 2000 Dec;19(4):357-68
11293888